Interpretation of the standardised reporting of burden of disease studies (STROBOD statement)_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Qiang ¹ ,  ZHAO Wenxia ¹ , Ding Yunhan ² , ZHANG Lihui ¹ , LIU Sutong ¹ , WANG Jingwen ¹ , CUI Jianjiao ¹ , KE Lixin ³ , ZHAO Xiaoxiao ⁴ , LI Jieyun ⁵ ,  LU Cuncun ⁶

1. The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, P. R. China;
2. Affiliated Hospital of Chengde Medical University Clinical Laboratory of Nanyuan District, Chengde 067000, P. R. China;
3. Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen 9713GZ, Netherlands;
4. Affiliated Hospital of Shandong University of TCM, Jinan 250014, P. R. China;
5. School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P. R. China;
6. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China;

Corresponding author：

ZHAO Wenxia, Email: wenxia-zhao@163.com; LU Cuncun, Email: lu17metrics@163.com

Keywords：

Burden of disease; STROBOD; Reporting standard; Disability-adjusted life year

DOI：

10.7507/1672-2531.202412058

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Clarifying the burden of disease is of great significance for determining the focus of healthcare and optimizing the allocation of medical resources. However, differences in research methods and assumptions often affect the comparability of different research results, thus leading to difficulties in healthcare decision-making. Disability-adjusted life year (DALY) is the most commonly used indicator to measure the burden of disease, but the reporting quality of disease burden studies using the DALY metric is uneven. To standardize the reporting of such studies, international scholars developed and recently published the STROBOD statement in Population Health Metrics. Its checklist includes seven parts: title, abstract, introduction, methods, results, discussion, and open science, involving a total of 28 items. To assist domestic scholars in better understanding and applying this reporting standard, this article interprets each item with published examples, aiming to improve the overall quality of disease burden research and provide high-quality evidence references for public health decision-making.

1.	李茜瑶, 周莹, 黄辉, 等. 疾病负担研究进展. 中国公共卫生, 2018, 34(5): 777-780.
2.	徐张燕, 张敏, 崔亚萍, 等. 疾病负担研究的发展与应用. 中国肿瘤, 2013, 22(8): 638-643.
3.	曾婷, 贾铁武. 全球疾病负担研究方法学进展及其对寄生虫病疾病负担的影响. 中国血吸虫病防治杂志, 2023, 35(3): 299-306.
4.	GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2133-2161.
5.	Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med, 2022, 28(10): 2019-2026.
6.	赵晓晓, 柯立鑫, 荀杨芹, 等. 1990-2021年中国与全球老年2型糖尿病的疾病负担调查与趋势预测. 中国全科医学, 2024.
7.	Chudasama YV, Khunti K, Gillies CL, et al. Estimates of years of life lost depended on the method used: tutorial and comparative investigation. J Clin Epidemiol, 2022, 150: 42-50.
8.	Devleesschauwer B, Charalampous P, Gorasso V, et al. Standardised reporting of burden of disease studies: the STROBOD statement. Popul Health Metr, 2024, 22(1): 28.
9.	Charalampous P, Haagsma JA, Jakobsen LS, et al. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices. Epidemiol Infect, 2023, 151: e19.
10.	Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet, 2016, 388(10062): e19-e23.
11.	陶立元, 甘戈, 刘珏. 卫生经济学评价报告标准2022解读. 中华流行病学杂志, 2023, 44(4): 667-672.
12.	卢存存, 张强, 雷超, 等. 使用队列和常规收集数据开展随机对照试验的报告清单(CONSORT-ROUTINE2021)解读. 中国循证医学杂志, 2022, 22(6): 731-738.
13.	Sun P, Yu C, Yin L, et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021. EClinicalMedicine, 2024, 74: 102713.
14.	GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol, 2020, 5(3): 245-266.
15.	杨宗明, 许健豪, 朱章航, 等. 中国人群早发性癌症的疾病负担分析及预测. 科学通报, 2024.
16.	Pires SM, Wyper GMA, Wengler A, et al. Burden of disease of COVID-19: strengthening the collaboration for national studies. Front Public Health, 2022, 10: 907012.
17.	Pires SM, Redondo HG, Espenhain L, et al. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic. BMC Public Health, 2022, 22(1): 1315.
18.	Haagsma JA, Maertens de Noordhout C, Polinder S, et al. Assessing disability weights based on the responses of 30, 660 people from four European countries. Popul Health Metr, 2015, 13: 10.
19.	Lin X, Bloom MS, Du Z, et al. Trends in disability-adjusted life years of lung cancer among women from 2004 to 2030 in Guangzhou, China: a population-based study. Cancer Epidemiol, 2019, 63: 101586.
20.	Plass D, Mangen MJ, Kraemer A, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect, 2014, 142(10): 2024-2035.
21.	Han S, Li S, Yang Y, et al. Mapping multimorbidity progression among 190 diseases. Commun Med (Lond), 2024, 4(1): 139.
22.	Gaunt ER, Harvala H, McIntyre C, et al. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol, 2011, 52(3): 215-221.
23.	Ditsuwan V, Veerman LJ, Barendregt JJ, et al. The national burden of road traffic injuries in Thailand. Popul Health Metr, 2011, 9(1): 2.
24.	Haneef R, Fayad M, Fouillet A, et al. Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020. PLoS One, 2023, 18(1): e0280990.
25.	Zhou XD, Chen QF, Yang W, et al. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine, 2024, 78: 102958.
26.	Akl EA, Hakoum M, Khamis A, et al. A framework is proposed for defining, categorizing, and assessing conflicts of interest in health research. J Clin Epidemiol, 2022, 149: 236-243.
27.	卢存存, 乔萌, 王子怡, 等. 康莱特注射液治疗非小细胞肺癌与肝癌论文的关键特征与安全性信息报告: 基于CONSORT-Harms的横断面调查. 中草药, 2023, 54(20): 6791-6797.
28.	沈力, 于祥田, 胡承. 临床研究论文撰写及报告规范的介绍. 中华糖尿病杂志, 2022, 14(2): 208-212.
29.	邢唯杰, 朱政, 周英凤, 等. 提高护理论文的报告质量—原始研究论文的报告规范. 护士进修杂志, 2020, 35(3): 258-261.
30.	李子悦, 方珈文, 林凯程. 1990-2019年中国归因于高体质指数的2型糖尿病疾病负担分析与预测研究. 中国全科医学, 2024, 27(9): 1126-1133,1148.
31.	汪哲, 李娜, 包云丽, 等. 1990-2019年中国归因于吸烟的消化系统疾病负担分析与模型预测. 中国循证医学杂志, 2023, 23(11): 1247-1252.
32.	王子怡, 卢存存, 黄家艺, 等. 中文期刊发表的预测模型系统评价文献调查与评价: 方法学质量和报告质量. 协和医学杂志, 2024, 15(4): 927-935.

1. 李茜瑶, 周莹, 黄辉, 等. 疾病负担研究进展. 中国公共卫生, 2018, 34(5): 777-780.
2. 徐张燕, 张敏, 崔亚萍, 等. 疾病负担研究的发展与应用. 中国肿瘤, 2013, 22(8): 638-643.
3. 曾婷, 贾铁武. 全球疾病负担研究方法学进展及其对寄生虫病疾病负担的影响. 中国血吸虫病防治杂志, 2023, 35(3): 299-306.
4. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2133-2161.
5. Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med, 2022, 28(10): 2019-2026.
6. 赵晓晓, 柯立鑫, 荀杨芹, 等. 1990-2021年中国与全球老年2型糖尿病的疾病负担调查与趋势预测. 中国全科医学, 2024.
7. Chudasama YV, Khunti K, Gillies CL, et al. Estimates of years of life lost depended on the method used: tutorial and comparative investigation. J Clin Epidemiol, 2022, 150: 42-50.
8. Devleesschauwer B, Charalampous P, Gorasso V, et al. Standardised reporting of burden of disease studies: the STROBOD statement. Popul Health Metr, 2024, 22(1): 28.
9. Charalampous P, Haagsma JA, Jakobsen LS, et al. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices. Epidemiol Infect, 2023, 151: e19.
10. Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet, 2016, 388(10062): e19-e23.
11. 陶立元, 甘戈, 刘珏. 卫生经济学评价报告标准2022解读. 中华流行病学杂志, 2023, 44(4): 667-672.
12. 卢存存, 张强, 雷超, 等. 使用队列和常规收集数据开展随机对照试验的报告清单(CONSORT-ROUTINE2021)解读. 中国循证医学杂志, 2022, 22(6): 731-738.
13. Sun P, Yu C, Yin L, et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021. EClinicalMedicine, 2024, 74: 102713.
14. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol, 2020, 5(3): 245-266.
15. 杨宗明, 许健豪, 朱章航, 等. 中国人群早发性癌症的疾病负担分析及预测. 科学通报, 2024.
16. Pires SM, Wyper GMA, Wengler A, et al. Burden of disease of COVID-19: strengthening the collaboration for national studies. Front Public Health, 2022, 10: 907012.
17. Pires SM, Redondo HG, Espenhain L, et al. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic. BMC Public Health, 2022, 22(1): 1315.
18. Haagsma JA, Maertens de Noordhout C, Polinder S, et al. Assessing disability weights based on the responses of 30, 660 people from four European countries. Popul Health Metr, 2015, 13: 10.
19. Lin X, Bloom MS, Du Z, et al. Trends in disability-adjusted life years of lung cancer among women from 2004 to 2030 in Guangzhou, China: a population-based study. Cancer Epidemiol, 2019, 63: 101586.
20. Plass D, Mangen MJ, Kraemer A, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect, 2014, 142(10): 2024-2035.
21. Han S, Li S, Yang Y, et al. Mapping multimorbidity progression among 190 diseases. Commun Med (Lond), 2024, 4(1): 139.
22. Gaunt ER, Harvala H, McIntyre C, et al. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol, 2011, 52(3): 215-221.
23. Ditsuwan V, Veerman LJ, Barendregt JJ, et al. The national burden of road traffic injuries in Thailand. Popul Health Metr, 2011, 9(1): 2.
24. Haneef R, Fayad M, Fouillet A, et al. Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020. PLoS One, 2023, 18(1): e0280990.
25. Zhou XD, Chen QF, Yang W, et al. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine, 2024, 78: 102958.
26. Akl EA, Hakoum M, Khamis A, et al. A framework is proposed for defining, categorizing, and assessing conflicts of interest in health research. J Clin Epidemiol, 2022, 149: 236-243.
27. 卢存存, 乔萌, 王子怡, 等. 康莱特注射液治疗非小细胞肺癌与肝癌论文的关键特征与安全性信息报告: 基于CONSORT-Harms的横断面调查. 中草药, 2023, 54(20): 6791-6797.
28. 沈力, 于祥田, 胡承. 临床研究论文撰写及报告规范的介绍. 中华糖尿病杂志, 2022, 14(2): 208-212.
29. 邢唯杰, 朱政, 周英凤, 等. 提高护理论文的报告质量—原始研究论文的报告规范. 护士进修杂志, 2020, 35(3): 258-261.
30. 李子悦, 方珈文, 林凯程. 1990-2019年中国归因于高体质指数的2型糖尿病疾病负担分析与预测研究. 中国全科医学, 2024, 27(9): 1126-1133,1148.
31. 汪哲, 李娜, 包云丽, 等. 1990-2019年中国归因于吸烟的消化系统疾病负担分析与模型预测. 中国循证医学杂志, 2023, 23(11): 1247-1252.
32. 王子怡, 卢存存, 黄家艺, 等. 中文期刊发表的预测模型系统评价文献调查与评价: 方法学质量和报告质量. 协和医学杂志, 2024, 15(4): 927-935.

Chinese Journal of Evidence-Based Medicine

Latest ArticlesInterpretation of the standardised reporting of burden of disease studies (STROBOD statement)

Abstract Full text Figures/Tables Video References Cited by

Format

Content